1. Medtech Insight
  2. >>Business

Google – With Help From Medtech And Aviation Groups – Launches Site To Help Build Ventilators

In an unlikely partnership, Google, AdvaMed and the Aerospace Industries Association have developed a portal to help medical ventilator manufacturers and component suppliers share information. The portal is intended to help avoid shortages in ventilator parts as the US continues to fight the coronavirus pandemic.

[2016-12-26] "Googleplex", Google Headquarters, Mountain View, California. Google logo on the office building is in this photo

Google LLC and the largest aviation and medtech lobby groups in the US have partnered to help efforts to develop more medical ventilators in the ongoing battle against the COVID-19 pandemic. While the issue of ventilator shortage has been in the news less in recent weeks, health experts are still concerned the crisis in the US is expected to get worse and continue to require more ventilators.

On 4 April, the Aerospace Industries Association (AIA), AdvaMed and Google announced that they developed a manufacturing portal at www.VentConnect.org that lets ventilation component suppliers and manufacturers share information to help produce ventilators

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 
• By Brian Bossetta

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.

More from Medtech Insight

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 
• By Brian Bossetta

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.

Mirvie Launches Predictive Blood Test For Preeclampsia

 
• By Marion Webb

Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.